100% mate…. However, all indications from PH and LC thus far has been that collaboration with BP is the objective….. The cash flow from Her Vaxx will enable the company to continue to deliver better outcomes for cancer patients by developing more novel treatments from within its existing pipeline, whilst simultaneously providing healthy dividends to shareholders and would be (will be) far better received by analysts and stock valuers as less speculative, not purely a growth stock….
This is the dream I have for IMU….. It’s steadily becoming closer and closer to a reality….
The company would benefit (and the SP) enormously from a future steady cash flow stream.. The long term benefits likely far exceed a small 2b buyout of Her Vaxx… I’d suggest it would be worth a far more substantial amount if it were to be sold
- Forums
- ASX - By Stock
- Ann: HER-Vaxx Immunotherapy Patent Granted in Europe
100% mate…. However, all indications from PH and LC thus far has...
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.4¢ |
Change
0.002(3.85%) |
Mkt cap ! $396.8M |
Open | High | Low | Value | Volume |
5.2¢ | 5.4¢ | 5.2¢ | $332.9K | 6.302M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 539790 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 1243558 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 539790 | 0.053 |
16 | 2365932 | 0.052 |
38 | 3917674 | 0.051 |
69 | 5785229 | 0.050 |
17 | 2359427 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 1243558 | 12 |
0.055 | 1844574 | 11 |
0.056 | 3114256 | 17 |
0.057 | 446030 | 6 |
0.058 | 800800 | 6 |
Last trade - 16.10pm 27/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online